Cite
HARVARD Citation
Garralda, E. et al. (n.d.). SO-010Preliminary results in colorectal cancer (CRC) patients enrolled in the GATTO study, a phase I study of Tomuzotuximab in combination with Gatipotuzumab in patients with EGFR positive solid tumors. Annals of oncology. p. . [Online].